Advanced Nurse Practitioner, Cancer Survivorship Care Plan, Long Term Cancer Side Effects, Pelvic Gynecological Cancer, Supportive Care in Cancer
Conditions
Brief summary
While the sequelae and toxicities after ovarian and endometrial cancer treatments are well described in the literature, the actual needs of patients for supportive oncology care remain poorly documented. Moreover, there is no data available to estimate the complexity of the oncological support care actions to be implemented. It is expected that an evaluation of the needs for supportive oncology care and its organization in day hospitalization for supportive oncology care will lead to an improvement in personalized post-cancer follow-up for these patients and to an improvement in their long-term quality of life.
Interventions
OTHERDay hospitalization in support care with meeting with support care professionals and coordination of actions by the advanced practice nurse
During this day hospitalization, patients will meet with different specialized professionals depending on the support care needs identified.
OTHERDelivery of useful information according to support care needs, concerning support care professionals in the city
Delivery of useful information according to support care needs, concerning support care professionals in the city
OTHERDelivery of a personalized post-cancer plan
Delivery of a personalized post-cancer plan
Sponsors
Ligue contre le cancer, France
Centre Francois Baclesse
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient \> 18 years old * Patient in complete remission after first-line treatment for endometrial or ovarian/fallopian tube/peritoneal cancer * Patient having completed her initial treatment; patients with maintenance treatments are eligible * Mastery of the French language * Patient with a telephone line * Patient affiliated to a social security scheme * Signature of informed consent before any specific procedure related to the study
Exclusion criteria
* Any associated medical or psychiatric conditions that could compromise the patient's ability to participate in the study * Patient with locoregional or metastatic recurrence * Patient deprived of liberty, under guardianship or curatorship * Simultaneous participation in a therapeutic clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients who used at least one of the oncology support services recommended in the Personalized After-Cancer Care Plan within 4 months of receiving the Personalized After-Cancer Care Plan | Up to 4 months |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients with sequelae after the initial treatment of their cancer, as well as the type and grade of the sequelae, based on the National Cancer Institute's screening grids (levels 1 and 2) during the consultation with a nurse referent | Up to 4 months |
| Description of the types of oncological support care needs identified | Up to 4 months |
| Proportion of patients with identified cancer care needs (at least one cancer care need to be implemented) 4 months after the submission of the Personalized Cancer Care Plan | Up to 4 months |
Countries
France
Outcome results
None listed